Summary

For breast cancer survivors who experience moderate or severe penetrative dyspareunia associated with vulvovaginal atrophy, application of a topical liquid lidocaine to the vulvar vestibule prior to penetration can prevent pain and offer these women comfortable intercourse. This article discusses the outcomes of the Therapy to Prevent Sexual Pain in Breast Cancer Survivors trial (NCT01539317).